Sight Sciences (SGHT) Total Non-Current Liabilities (2020 - 2026)
Sight Sciences (SGHT) posted quarterly Total Non-Current Liabilities of $54.9 million for Q1 2026, up 6.18% year-over-year from $51.7 million in Q1 2025, and up 6.96% quarter-over-quarter from $51.3 million in Q4 2025.
Sight Sciences (SGHT) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Sight Sciences' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $54.9 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 6.18% year-over-year to $54.9 million; the TTM figure through Mar 2026 stood at $54.9 million (up 6.18% YoY), while the FY2025 annual figure was $51.3 million, down 6.38% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $54.9 million, up from $51.3 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $54.9 million in Q1 2026, with the low at $44.0 million in Q4 2023.
- The 5-year median for Total Non-Current Liabilities is $50.2 million (2023), against an average of $49.8 million.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities slipped 16.99% in 2023, then advanced 24.71% in 2024.
- Sight Sciences' Total Non-Current Liabilities stood at $53.0 million in 2022, then slipped by 16.99% to $44.0 million in 2023, then rose by 24.71% to $54.8 million in 2024, then retreated by 6.38% to $51.3 million in 2025, then climbed by 6.96% to $54.9 million in 2026.
- Business Quant data shows SGHT's Total Non-Current Liabilities at $54.9 million in Q1 2026, $51.3 million in Q4 2025, and $51.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Sight Sciences | 456.76 Mn | 377.01 Mn | 21.37 Mn | 51.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 51.14 Mn |
| Mar 31, 2026 | 54.90 Mn |
| Dec 31, 2025 | 51.33 Mn |
| Sep 30, 2025 | 51.95 Mn |
| Jun 30, 2025 | 51.76 Mn |
| Mar 31, 2025 | 51.71 Mn |
| Dec 31, 2024 | 54.82 Mn |
| Sep 30, 2024 | 48.57 Mn |
| Jun 30, 2024 | 47.06 Mn |
| Mar 31, 2024 | 45.39 Mn |
| Dec 31, 2023 | 43.96 Mn |
| Sep 30, 2023 | 48.10 Mn |
| Jun 30, 2023 | 49.12 Mn |
| Mar 31, 2023 | 50.23 Mn |
| Dec 31, 2022 | 52.96 Mn |
| Sep 30, 2022 | 50.54 Mn |
| Jun 30, 2022 | 47.18 Mn |
| Mar 31, 2022 | 46.64 Mn |
| Dec 31, 2021 | 46.16 Mn |
| Sep 30, 2021 | 44.73 Mn |